Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 35
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Oxid Med Cell Longev ; 2020: 1813798, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32908623

RESUMEN

Hemp seed has been used as a traditional oriental medicine and health food in China for centuries. Polysaccharides from hemp seed (HSP) exhibit important properties of intestinal protection, but there are limited data on the specific underlying mechanism. The primary objective of this study was to investigate the protective effect of HSP on intestinal oxidative damage induced by cyclophosphamide (Cy) in mice. The results showed that pretreatment with HSP significantly increased the average daily gain, thymus index, spleen index, superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activity in serum and ileal homogenate and significantly reduced malondialdehyde (MDA) content in ileal homogenate. In addition, the expression levels of SOD, GSH-Px, Nrf2, heme oxidase-1 (HO-1), and quinoneoxidoreductase-1 (NQO1) mRNA in ileal homogenate were significantly increased. Western blot results showed that HSP significantly upregulated the expression of Nrf2 protein and downregulated the expression of Keap1 protein in the ileum. Collectively, our findings indicated that HSP had protective effects on intestinal oxidative damage induced by Cy in mice, and its mechanism might be related to the activation of Nrf2-Keap1 signaling pathway.


Asunto(s)
Cannabis/química , Ciclofosfamida/efectos adversos , Proteína 1 Asociada A ECH Tipo Kelch/metabolismo , Factor 2 Relacionado con NF-E2/metabolismo , Estrés Oxidativo/efectos de los fármacos , Polisacáridos/farmacología , Semillas/química , Transducción de Señal , Animales , Peso Corporal/efectos de los fármacos , Catalasa/sangre , Glutatión Peroxidasa/sangre , Íleon/metabolismo , Inactivación Metabólica/genética , Yeyuno/efectos de los fármacos , Yeyuno/ultraestructura , Masculino , Malondialdehído/metabolismo , Ratones Endogámicos ICR , Monosacáridos/análisis , Especificidad de Órganos/efectos de los fármacos , Sustancias Protectoras/farmacología , Transducción de Señal/efectos de los fármacos , Espectroscopía Infrarroja por Transformada de Fourier , Superóxido Dismutasa/sangre
2.
J Am Coll Nutr ; 39(2): 94-102, 2020 02.
Artículo en Inglés | MEDLINE | ID: mdl-32027241

RESUMEN

Due to their genomic variants, some individuals are more highly affected by toxicants than others. Toxicant metabolizing and activating variants have been linked with a wide variety of health issues including an increased risk of miscarriages, birth defects, Alzheimer's, benzene toxicity, mercury toxicity and cancer. The study of genomics allows a clinician to identify pathways that are less effective and then gives the clinician the opportunity to counsel their patients about diet, supplements and lifestyle modifications that can improve the function of these pathways or compensate to some extent for their deficits. This article will review a few of these critical pathways relating to phase I and phase 2 detox such as GSTP1, GPX1, GSTT1 deletions, PON1 and some of the CYP 450 system as examples of how an individual's genomic vulnerabilities to toxicants can be addressed by upregulating or downregulating specific pathways via genomically targeted use of foods, supplements and lifestyle changes.


Asunto(s)
Trastornos Químicamente Inducidos/genética , Exposición a Riesgos Ambientales/efectos adversos , Contaminantes Ambientales/toxicidad , Inactivación Metabólica/genética , Terapia Nutricional , Benceno/toxicidad , Trastornos Químicamente Inducidos/prevención & control , Trastornos Químicamente Inducidos/terapia , Sistema Enzimático del Citocromo P-450/genética , Predisposición Genética a la Enfermedad , Glutatión/metabolismo , Glutatión Transferasa/genética , Humanos , Mercurio/toxicidad , Mutación , Plaguicidas/toxicidad , Medicina de Precisión , Especies Reactivas de Oxígeno
3.
Artículo en Inglés | MEDLINE | ID: mdl-31048018

RESUMEN

Enrofloxacin (ENR) is the most commonly used antibiotic in crustacean farming in China. Diet supplementation with lactic acid (LA) may, however, affect the efficacy and safety of ENR-based drugs. The aims of this study were to investigate the effects of LA on drug residues and elimination of oral ENR in Chinese mitten crab (Eriocheir sinensis) and to determine ENR and gene expression levels of drug-metabolizing enzymes in the hepatopancreas. To this end, ENR was orally administered to the crabs at a dose of 10.0 mg kg-1 body weight on the eighth day after feeding diets supplemented with 0.3%LA. The results showed that ENR levels in the hepatopancreas were significantly different at 1 and 12 h between the ENR and ENR + 0.3% LA groups (P < 0.05). Lactic acid did not significantly affect the expression of CYP2A (phase I). However, the expressions of CYP3 (phase I) and GST (phase II) were significantly up-regulated by LA during the elimination process of ENR (6-24 h). At Tmax (1 h), the expression of phosphoenolpyruvate carboxykinase (PEPCK) was induced and expression of succinate dehydrogenase (SDH) was inhibited by LA. Both of these enzymes were significantly inhibited during the elimination process of ENR. The results suggest that LA contributes to the elimination of ENR, and thus, enhances hepatopancreas biotransformation and anti-injury capacity in E. sinensis.


Asunto(s)
Braquiuros/efectos de los fármacos , Enrofloxacina/farmacocinética , Inactivación Metabólica/efectos de los fármacos , Ácido Láctico/farmacología , Administración Oral , Animales , Antibacterianos/administración & dosificación , Antibacterianos/farmacocinética , Acuicultura , Hidrocarburo de Aril Hidroxilasas/genética , Hidrocarburo de Aril Hidroxilasas/metabolismo , Braquiuros/enzimología , Familia 3 del Citocromo P450/genética , Familia 3 del Citocromo P450/metabolismo , Suplementos Dietéticos , Metabolismo Energético/efectos de los fármacos , Metabolismo Energético/genética , Enrofloxacina/administración & dosificación , Regulación de la Expresión Génica/efectos de los fármacos , Hepatopáncreas/efectos de los fármacos , Hepatopáncreas/metabolismo , Inactivación Metabólica/genética , Esteroide Hidroxilasas/genética , Esteroide Hidroxilasas/metabolismo
4.
Int J Biol Macromol ; 112: 745-753, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29410059

RESUMEN

Organoselemium compounds possess strong antioxidant activity as well as protecting cells from DNA damage, mitochondrial injury, lipid peroxidation, protein denaturation and cell death. Herein, we used an in vitro oxidative model to further investigate the antioxidant effects of a novel organoselemium compound, low molecular-weight seleno-aminopolysaccharides (LSA) in intestinal porcine epithelial cells (IPEC-1), and the molecular mechanisms of these effects. Analysis by MTT assay showed that LSA could significantly increase the viability of IPEC-1 cells compared to cells exposed to H2O2. We found that the levels of different antioxidant enzymes could dramatically increase in LSA pretreatment group compared to H2O2 treatment group. Furthermore, LSA significantly increased the gene expression of antioxidant enzymes and phase 2 detoxifying enzymes in IPEC-1 cells, as measured by qRT-PCR. In addition, LSA up-regulated the expression level of intracellular transcription factor NF-E2-related factor 2 (Nrf2) and inhibited the level of kelch-like ECH-associated protein 1 (Keap1) with western blot analysis. Collectively, the present study suggested that LSA has the protective effect of IPEC-1 cells against H2O2-induecd oxidative stress, and its mechanism may be related to activation of Keap1/Nrf2 signaling pathway in intestinal epithelial cells.


Asunto(s)
Enterocitos/patología , Peróxido de Hidrógeno/toxicidad , Estrés Oxidativo/efectos de los fármacos , Polisacáridos/farmacología , Sustancias Protectoras/farmacología , Selenio/farmacología , Animales , Antioxidantes/metabolismo , Catalasa/genética , Catalasa/metabolismo , Muerte Celular/efectos de los fármacos , Línea Celular , Citoprotección/efectos de los fármacos , Enterocitos/efectos de los fármacos , Enterocitos/enzimología , Regulación de la Expresión Génica/efectos de los fármacos , Glutatión Peroxidasa/genética , Glutatión Peroxidasa/metabolismo , Inactivación Metabólica/efectos de los fármacos , Inactivación Metabólica/genética , Proteína 1 Asociada A ECH Tipo Kelch/genética , Proteína 1 Asociada A ECH Tipo Kelch/metabolismo , L-Lactato Deshidrogenasa/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Malondialdehído/metabolismo , Peso Molecular , Factor 2 Relacionado con NF-E2/genética , Factor 2 Relacionado con NF-E2/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Superóxido Dismutasa/genética , Superóxido Dismutasa/metabolismo , Sus scrofa
5.
Arch Toxicol ; 92(1): 383-399, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-28762043

RESUMEN

Drug-induced liver injury (DILI) has a considerable impact on human health and is a major challenge in drug safety assessments. DILI is a frequent cause of liver injury and a leading reason for post-approval drug regulatory actions. Considerable variations in the expression levels of both cytochrome P450 (CYP) and conjugating enzymes have been described in humans, which could be responsible for increased susceptibility to DILI in some individuals. We herein explored the feasibility of the combined use of HepG2 cells co-transduced with multiple adenoviruses that encode drug-metabolising enzymes, and a high-content screening assay to evaluate metabolism-dependent drug toxicity and to identify metabolic phenotypes with increased susceptibility to DILI. To this end, HepG2 cells with different expression levels of specific drug-metabolism enzymes (CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4, GSTM1 and UGT2B7) were exposed to nine drugs with reported hepatotoxicity. A panel of pre-lethal mechanistic parameters (mitochondrial superoxide production, mitochondrial membrane potential, ROS production, intracellular calcium concentration, apoptotic nuclei) was used. Significant differences were observed according to the level of expression and/or the combination of several drug-metabolism enzymes in the cells created ad hoc according to the enzymes implicated in drug toxicity. Additionally, the main mechanisms implicated in the toxicity of the compounds were also determined showing also differences between the different types of cells employed. This screening tool allowed to mimic the variability in drug metabolism in the population and showed a highly efficient system for predicting human DILI, identifying the metabolic phenotypes associated with increased DILI risk, and indicating the mechanisms implicated in their toxicity.


Asunto(s)
Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Familia 2 del Citocromo P450/genética , Evaluación Preclínica de Medicamentos/métodos , Pruebas de Toxicidad/métodos , Adenoviridae/genética , Familia 2 del Citocromo P450/metabolismo , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Células Hep G2 , Ensayos Analíticos de Alto Rendimiento/métodos , Humanos , Inactivación Metabólica/genética , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo
6.
BMC Plant Biol ; 17(1): 56, 2017 02 28.
Artículo en Inglés | MEDLINE | ID: mdl-28245791

RESUMEN

BACKGROUND: Pesticides cause oxidative stress to plants and their residues persist in plant parts, which are a major concern for the environment as well as human health. Brassinosteroids (BRs) are known to protect plants from abiotic stress conditions including pesticide toxicity. The present study demonstrated the effects of seed-soaking with 24-epibrassinolide (EBR) on physiological responses of 10-day old Brassica juncea seedlings grown under imidacloprid (IMI) toxicity. RESULTS: In the seedlings raised from EBR-treated seeds and grown under IMI toxicity, the contents of hydrogen peroxide (H2O2) and superoxide anion (O.2-) were decreased, accompanied by enhanced activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), glutathione-S-transferase (GST), guaiacol peroxidase (POD) and the content of glutathione (GSH). As compared to controls, the gene expressions of SOD, CAT, GR, POD, NADH (NADH-ubiquinone oxidoreductase), CXE (carboxylesterase), GSH-S (glutathione synthase), GSH-T (glutathione transporter-1), P450 (cytochrome P450 monooxygenase) and GST1-3,5-6 were enhanced in the seedlings raised from EBR-treated seeds and grown in IMI supplemented substratum. However, expression of RBO (respiratory burst oxidase, the gene responsible for H2O2 production) was decreased in seedlings raised from EBR treated seeds and grown under IMI toxicity. Further, the EBR seed treatment decreased IMI residues by more than 38% in B. juncea seedlings. CONCLUSIONS: The present study revealed that EBR seed soaking can efficiently reduce oxidative stress and IMI residues by modulating the gene expression of B. juncea under IMI stress. In conclusion, exogenous EBR application can protect plants from pesticide phytotoxicity.


Asunto(s)
Brasinoesteroides/farmacología , Imidazoles/antagonistas & inhibidores , Insecticidas/antagonistas & inhibidores , Planta de la Mostaza/efectos de los fármacos , Planta de la Mostaza/genética , Nitrocompuestos/antagonistas & inhibidores , Reguladores del Crecimiento de las Plantas/farmacología , Esteroides Heterocíclicos/farmacología , Expresión Génica/efectos de los fármacos , Genes de Plantas/efectos de los fármacos , Glutatión/metabolismo , Imidazoles/toxicidad , Inactivación Metabólica/genética , Insecticidas/toxicidad , Planta de la Mostaza/enzimología , Neonicotinoides , Nitrocompuestos/toxicidad , Estrés Oxidativo , Especies Reactivas de Oxígeno/metabolismo , Semillas/efectos de los fármacos , Semillas/genética
7.
J Nutr Biochem ; 43: 68-77, 2017 05.
Artículo en Inglés | MEDLINE | ID: mdl-28264783

RESUMEN

Breast cancer is the most common malignancy among women worldwide. In addition to reproductive factors, environmental factors such as nutrition and xenobiotic exposure have a role in the etiology of this malignancy. A stimulating and a potentially protective effect on experimental breast cancer has been previously described for high corn oil and high extra-virgin olive oil diets, respectively. This work investigates the effect of these lipids on the metabolism of 7,12-dimethylbenz(a)anthracene (DMBA), a polycyclic aromatic hydrocarbon that can initiate carcinogenesis and its consequences in an experimental rat breast cancer model. The PUFA n-6-enriched diet increased expression of Phase I enzymes prior to DMBA administration and raised the activity of CYP1s in the hours immediately after induction, while reducing the activity of Phase II enzymes, mainly NQO1. The levels of reactive metabolites measured in plasma by GC-MS and DMBA-DNA adducts in the mammary gland of the animals fed the high corn oil diet were also higher than in the other groups. On the other hand, the high extra-virgin olive oil diet and the control low-fat diet exhibited better coordinated Phase I and Phase II activity, with a lower production of reactive metabolites and less DNA damage in the mammary gland. The concordance between these effects and the different efficacy of the carcinogenesis process due to the dietary treatment suggest that lipids may differently modify mammary gland susceptibility or resistance to cancer initiation over the exposure to environmental carcinogens. SUMMARY: Dietary lipids influence the initiation of DMBA-induced mammary cancer through the modulation of liver xenobiotic metabolism, formation of reactive metabolites and subsequent DNA damage in the target tissue.


Asunto(s)
Daño del ADN/efectos de los fármacos , Inactivación Metabólica/efectos de los fármacos , Lípidos/farmacología , Neoplasias Mamarias Experimentales/prevención & control , Xenobióticos/farmacocinética , 9,10-Dimetil-1,2-benzantraceno/sangre , 9,10-Dimetil-1,2-benzantraceno/toxicidad , Animales , Aceite de Maíz/farmacología , Citocromo P-450 CYP1A1/genética , Citocromo P-450 CYP1B1/genética , Suplementos Dietéticos , Femenino , Inactivación Metabólica/genética , Hígado/efectos de los fármacos , Hígado/metabolismo , Neoplasias Mamarias Experimentales/inducido químicamente , Neoplasias Mamarias Experimentales/patología , NAD(P)H Deshidrogenasa (Quinona)/genética , Aceite de Oliva/farmacología , Ratas Sprague-Dawley
8.
Sci Rep ; 7: 41255, 2017 01 23.
Artículo en Inglés | MEDLINE | ID: mdl-28112264

RESUMEN

The western honeybee (Apis mellifera) is essential for the global economy due to its important role in ecosystems and agriculture as a pollinator of numerous flowering plants and crops. Pesticide abuse has greatly impacted honeybees and caused tremendous loss of honeybee colonies worldwide. The reasons for colony loss remain unclear, but involvement of pesticides and pathogen-pesticide interactions has been hypothesized. Histone deacetylase inhibitors (HDACis) inhibit the activity of histone acetylase, which causes the hyperacetylation of histone cores and influences gene expression. In this study, sodium butyrate, an HDACi, was used as a dietary supplement for honeybees; after treatment, gene expression profiles were analyzed using quantitative PCR. The results showed that sodium butyrate up-regulated genes involved in anti-pathogen and detoxification pathways. The bioassay results showed that honeybees treated with sodium butyrate were more tolerant to imidacloprid. Additionally, sodium butyrate strengthened the immune response of honeybees to invasions of Nosema ceranae and viral infections. We also performed a bioassay in which honeybees were exposed to pesticides and pathogens. Our results provide additional data regarding the mechanism by which honeybees react to stress and the potential application of HDACis in beekeeping.


Asunto(s)
Abejas/efectos de los fármacos , Abejas/genética , Regulación de la Expresión Génica/efectos de los fármacos , Histonas/metabolismo , Transducción de Señal/genética , Acetilación/efectos de los fármacos , Animales , Péptidos Catiónicos Antimicrobianos/farmacología , Abejas/inmunología , Abejas/microbiología , Ácido Butírico/farmacología , Caspasa 3/metabolismo , Inactivación Metabólica/efectos de los fármacos , Inactivación Metabólica/genética , Microsporidiosis/genética , Microsporidiosis/patología , Neonicotinoides/farmacología , Nitrocompuestos/farmacología , Nosema/efectos de los fármacos , Nosema/fisiología , Transducción de Señal/efectos de los fármacos
9.
Cancer Prev Res (Phila) ; 9(7): 598-606, 2016 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-27099270

RESUMEN

Cigarette smoke contains relatively large quantities of volatile organic toxicants or carcinogens such as benzene, acrolein, and crotonaldehyde. Among their detoxification products are mercapturic acids formed from glutathione conjugation, catalyzed in part by glutathione S-transferases (GST). A randomized phase II clinical trial with a crossover design was conducted to evaluate the effect of 2-phenethyl isothiocyanate (PEITC), a natural product formed from gluconasturtiin in certain cruciferous vegetables, on the detoxification of benzene, acrolein, and crotonaldehyde in 82 cigarette smokers. Urinary mercapturic acids of benzene, acrolein, and crotonaldehyde at baseline and during treatment were quantified. Overall, oral PEITC supplementation increased the mercapturic acid formed from benzene by 24.6% (P = 0.002) and acrolein by 15.1% (P = 0.005), but had no effect on crotonaldehyde. A remarkably stronger effect was observed among subjects with the null genotype of both GSTM1 and GSTT1: in these individuals, PEITC increased the detoxification metabolite of benzene by 95.4% (P < 0.001), of acrolein by 32.7% (P = 0.034), and of crotonaldehyde by 29.8% (P = 0.006). In contrast, PEITC had no effect on these mercapturic acids in smokers possessing both genes. PEITC had no effect on the urinary oxidative stress biomarker 8-iso-prostaglandin F2α or the inflammation biomarker prostaglandin E2 metabolite. This trial demonstrates an important role of PEITC in detoxification of environmental carcinogens and toxicants which also occur in cigarette smoke. The selective effect of PEITC on detoxification in subjects lacking both GSTM1 and GSTT1 genes supports the epidemiologic findings of stronger protection by dietary isothiocyanates against the development of lung cancer in such individuals. Cancer Prev Res; 9(7); 598-606. ©2016 AACR.


Asunto(s)
Carcinógenos/metabolismo , Inhibidores Enzimáticos/uso terapéutico , Inactivación Metabólica/efectos de los fármacos , Isotiocianatos/uso terapéutico , Nicotiana/química , Fumar/tratamiento farmacológico , Acroleína/metabolismo , Adulto , Aldehídos/metabolismo , Benceno/metabolismo , Estudios Cruzados , Femenino , Glutatión Transferasa/genética , Humanos , Inactivación Metabólica/genética , Masculino , Persona de Mediana Edad , Polimorfismo de Nucleótido Simple , Humo/efectos adversos , Fumar/efectos adversos , Fumar/metabolismo , Nicotiana/efectos adversos , Nicotiana/metabolismo , Compuestos Orgánicos Volátiles/efectos adversos , Compuestos Orgánicos Volátiles/metabolismo
10.
Biochim Biophys Acta ; 1859(9): 1072-1082, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-27041449

RESUMEN

The pregnane X receptor (PXR) is a nuclear receptor that is traditionally thought to be specialized for sensing xenobiotic exposure. In concurrence with this feature PXR was originally identified to regulate drug-metabolizing enzymes and transporters. During the last ten years it has become clear that PXR harbors broader functions. Evidence obtained both in experimental animals and humans indicate that ligand-activated PXR regulates hepatic glucose and lipid metabolism and affects whole body metabolic homeostasis. Currently, the consequences of PXR activation on overall metabolic health are not yet fully understood and varying results on the effect of PXR activation or knockout on metabolic disorders and weight gain have been published in mouse models. Rifampicin and St. John's wort, the prototypical human PXR agonists, impair glucose tolerance in healthy volunteers. Chronic exposure to PXR agonists could potentially represent a risk factor for diabetes and metabolic syndrome. This article is part of a Special Issue entitled: Xenobiotic nuclear receptors: New Tricks for An Old Dog, edited by Dr. Wen Xie.


Asunto(s)
Diabetes Mellitus/metabolismo , Inactivación Metabólica/genética , Hígado/metabolismo , Síndrome Metabólico/metabolismo , Receptores de Esteroides/metabolismo , Animales , Diabetes Mellitus/genética , Diabetes Mellitus/patología , Regulación de la Expresión Génica , Gluconeogénesis/genética , Glucosa/metabolismo , Glucólisis/efectos de los fármacos , Glucólisis/genética , Humanos , Hypericum/efectos adversos , Hypericum/química , Lipogénesis/genética , Hígado/efectos de los fármacos , Hígado/patología , Síndrome Metabólico/genética , Síndrome Metabólico/patología , Receptor X de Pregnano , Receptores de Esteroides/genética , Rifampin/efectos adversos , Transducción de Señal
11.
Insect Biochem Mol Biol ; 69: 105-14, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26392061

RESUMEN

The selenium-dependent glutathione peroxidase (SeGPx) is a well-studied enzyme that detoxifies organic and hydrogen peroxides and provides cells or extracellular fluids with a key antioxidant function. The presence of a SeGPx has not been unequivocally demonstrated in insects. In the present work, we identified the gene and studied the function of a Rhodnius prolixus SeGPx (RpSeGPx). The RpSeGPx mRNA presents the UGA codon that encodes the active site selenocysteine (Sec) and a corresponding Sec insertion sequence (SECIS) in the 3' UTR region. The encoded protein includes a signal peptide, which is consistent with the high levels of GPx enzymatic activity in the insect's hemolymph, and clusters phylogenetically with the extracellular mammalian GPx03. This result contrasts with all other known insect GPxs, which use a cysteine residue instead of Sec and cluster with the mammalian phospholipid hydroperoxide GPx04. RpSeGPx is widely expressed in insect organs, with higher expression levels in the fat body. RNA interference (RNAi) was used to reduce RpSeGPx gene expression and GPx activity in the hemolymph. Adult females were apparently unaffected by RpSeGPx RNAi, whereas first instar nymphs showed a three-day delay in ecdysis. Silencing of RpSeGPx did not alter the gene expression of the antioxidant enzymes catalase, xanthine dehydrogenase and a cysteine-GPx, but it reduced the levels of the dual oxidase and NADPH oxidase 5 transcripts that encode for enzymes releasing extracellular hydrogen peroxide/superoxide. Collectively, our data suggest that RpSeGPx functions in the regulation of extracellular (hemolymph) redox homeostasis of R. prolixus.


Asunto(s)
Glutatión Peroxidasa/química , Glutatión Peroxidasa/genética , Rhodnius/enzimología , Rhodnius/genética , Selenio/química , Animales , Femenino , Inactivación Metabólica/genética , Muda , Filogenia , Interferencia de ARN , Conejos , Rhodnius/crecimiento & desarrollo , Selenocisteína/química
12.
World J Gastroenterol ; 21(35): 10091-103, 2015 Sep 21.
Artículo en Inglés | MEDLINE | ID: mdl-26401074

RESUMEN

AIM: To investigate the effects of broccoli sprout extract (BSEx) on liver gene expression and acute liver injury in the rat. METHODS: First, the effects of BSEx on liver gene expression were examined. Male rats were divided into two groups. The Control group was fed the AIN-76 diet, and the BSEx group was fed the AIN-76 diet containing BSEx. After a 10-d feeding period, rats were sacrificed and their livers were used for DNA microarray and real-time reverse transcription-polymerase chain reaction (RT-PCR) analyses. Next, the effects of BSEx on acute liver injury were examined. In experiments using acute liver injury models, 1000 mg/kg acetaminophen (APAP) or 350 mg/kg D-galactosamine (D-GalN) was used to induce injury. These male rats were divided into four groups: Control, BSEx, Inducer (APAP or D-GalN), and Inducer+BSEx. The feeding regimens were identical for the two analyses. Twenty-four hours following APAP administration via p.o. or D-GalN administration via i.p., rats were sacrificed to determine serum aspartate transaminase (AST) and alanine transaminase (ALT) levels, hepatic glutathione (GSH) and thiobarbituric acid-reactive substances accumulation and glutathione-S-transferase (GST) activity. RESULTS: Microarray and real-time RT-PCR analyses revealed that BSEx upregulated the expression of genes related to detoxification and glutathione synthesis in normal rat liver. The levels of AST (70.91 ± 15.74 IU/mL vs 5614.41 ± 1997.83 IU/mL, P < 0.05) and ALT (11.78 ± 2.08 IU/mL vs 1297.71 ± 447.33 IU/mL, P < 0.05) were significantly suppressed in the APAP + BSEx group compared with the APAP group. The level of GSH (2.61 ± 0.75 nmol/g tissue vs 1.66 ± 0.59 nmol/g tissue, P < 0.05) and liver GST activity (93.19 ± 16.55 U/g tissue vs 51.90 ± 16.85 U/g tissue, P < 0.05) were significantly increased in the APAP + BSEx group compared with the APAP group. AST (4820.05 ± 3094.93 IU/mL vs 12465.63 ± 3223.97 IU/mL, P < 0.05) and ALT (1808.95 ± 1014.04 IU/mL vs 3936.46 ± 777.52 IU/mL, P < 0.05) levels were significantly suppressed in the D-GalN + BSEx group compared with the D-GalN group, but the levels of AST and ALT in the D-GalN + BSEx group were higher than those in the APAP + BSEx group. The level of GST activity was significantly increased in the D-GalN + BSEx group compared with the D-GalN group (98.04 ± 15.75 U/g tissue vs 53.15 ± 8.14 U/g tissue, P < 0.05). CONCLUSION: We demonstrated that BSEx protected the liver from various types of xenobiotic substances through induction of detoxification enzymes and glutathione synthesis.


Asunto(s)
Brassica/química , Enfermedad Hepática Inducida por Sustancias y Drogas/prevención & control , Regulación de la Expresión Génica/efectos de los fármacos , Hígado/efectos de los fármacos , Extractos Vegetales/farmacología , Sustancias Protectoras/farmacología , Acetaminofén , Animales , Biomarcadores/sangre , Enfermedad Hepática Inducida por Sustancias y Drogas/sangre , Enfermedad Hepática Inducida por Sustancias y Drogas/genética , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Citoprotección , Modelos Animales de Enfermedad , Galactosamina , Perfilación de la Expresión Génica/métodos , Glutatión/metabolismo , Inactivación Metabólica/efectos de los fármacos , Inactivación Metabólica/genética , Hígado/metabolismo , Hígado/patología , Masculino , Análisis de Secuencia por Matrices de Oligonucleótidos , Fitoterapia , Extractos Vegetales/aislamiento & purificación , Plantas Medicinales , Sustancias Protectoras/aislamiento & purificación , Ratas Wistar , Reacción en Cadena en Tiempo Real de la Polimerasa , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Plantones , Factores de Tiempo
13.
Biomed Res Int ; 2015: 657159, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26339628

RESUMEN

The issue of herb-drug interactions has been widely reported. Herbal ingredients can activate nuclear receptors and further induce the gene expression alteration of drug-metabolizing enzyme and/or transporter. Therefore, the herb-drug interaction will happen when the herbs and drugs are coadministered. This kind of interaction is called inductive herb-drug interactions. Pregnane X Receptor (PXR) and drug-metabolizing target genes are involved in most of inductive herb-drug interactions. To predict this kind of herb-drug interaction, the protocol could be simplified to only screen agonists of PXR from herbs because the relations of drugs with their metabolizing enzymes are well studied. Here, a combinational in silico strategy of pharmacophore modelling and docking-based rank aggregation (DRA) was employed to identify PXR's agonists. Firstly, 305 ingredients were screened out from 820 ingredients as candidate agonists of PXR with our pharmacophore model. Secondly, DRA was used to rerank the result of pharmacophore filtering. To validate our prediction, a curated herb-drug interaction database was built, which recorded 380 herb-drug interactions. Finally, among the top 10 herb ingredients from the ranking list, 6 ingredients were reported to involve in herb-drug interactions. The accuracy of our method is higher than other traditional methods. The strategy could be extended to studies on other inductive herb-drug interactions.


Asunto(s)
Interacciones de Hierba-Droga/genética , Simulación del Acoplamiento Molecular , Plantas Medicinales/química , Receptores de Esteroides/química , Simulación por Computador , Bases de Datos Factuales , Expresión Génica , Humanos , Inactivación Metabólica/genética , Modelos Moleculares , Receptor X de Pregnano , Receptores de Esteroides/agonistas , Receptores de Esteroides/genética
15.
Int J Food Sci Nutr ; 65(8): 981-8, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25156454

RESUMEN

Sesaminol triglucoside is a major lignin in sesame meal and has a methylenedioxyphenyl group and multiple functions in vivo. As a tetrahydrofurofuran type lignan, sesaminol triglucoside is metabolized to mammalian lignans. This investigation studies the effect of sesaminol triglucoside and its tetrahydrofuranoid metabolites (sesaminol, 2-episesaminol, hydroxymethyl sesaminol-tetrahydrofuran, enterolactone, and enterodiol) on gene expression in primary rat hepatocytes using a DNA microarray. Sesame lignans significantly affected the expression of xenobiotic-induced transcripts of cytochrome P450, solute carrier (SLC), and ATP-binding cassette (ABC) transporters. Changes in gene expression were generally greater in response to metabolites with methylenedioxyphenyl moieties (sesaminol triglucoside, sesaminol, and 2-episesaminol) than to the tetrahydrofuranoid metabolites (hydroxymethyl sesaminol-tetrahydrofuran, enterolactone, and enterodiol). Tetrahydrofuran lignans, such as sesaminol triglucoside, sesamin, hydroxymethyl sesaminol-tetrahydrofuran, and sesaminol changed the expression of ABC transporters.


Asunto(s)
Transportadoras de Casetes de Unión a ATP/metabolismo , Dioxoles/metabolismo , Furanos/metabolismo , Glucósidos/metabolismo , Lignanos/metabolismo , Hígado/metabolismo , Sesamum/química , 4-Butirolactona/análogos & derivados , 4-Butirolactona/metabolismo , Animales , Sistema Enzimático del Citocromo P-450/metabolismo , Dioxoles/farmacología , Furanos/farmacología , Expresión Génica , Perfilación de la Expresión Génica , Hepatocitos/metabolismo , Inactivación Metabólica/efectos de los fármacos , Inactivación Metabólica/genética , Lignanos/farmacología , Mamíferos , Extractos Vegetales/metabolismo , Extractos Vegetales/farmacología , Ratas Sprague-Dawley , Semillas/química
16.
Biosci Biotechnol Biochem ; 78(12): 2008-13, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25052035

RESUMEN

Caenorhabditis elegans is a versatile, whole-organism model for bioactivity screening. However, this worm has extensive defensive mechanisms against xenobiotics which limit its use for screening of pharmacologically active compounds. In this study, we report that knockdown of nhr-8, a gene involved in the xenobiotic response, increased the worm's sensitivity to the lipid-reducing effects of some isoquinoline alkaloids, especially berberine. On the other hand, crude extract of rhizome and cultured cells showed enhanced biological activity compared to the pure alkaloids in wild type worm, but this enhanced activity was not detected in nhr-8 RNAi worm, suggesting that some components in cell extracts might interfere with the defense response in this worm. The possibility of using C. elegans as a model for screening bioactive chemicals is discussed.


Asunto(s)
Benzofenantridinas/farmacología , Berberina/farmacología , Proteínas de Caenorhabditis elegans/genética , Caenorhabditis elegans/efectos de los fármacos , Caenorhabditis elegans/genética , Coptis/química , Isoquinolinas/farmacología , Receptores Citoplasmáticos y Nucleares/genética , Animales , Caenorhabditis elegans/metabolismo , Proteínas de Caenorhabditis elegans/antagonistas & inhibidores , Proteínas de Caenorhabditis elegans/metabolismo , Regulación de la Expresión Génica , Ensayos Analíticos de Alto Rendimiento , Inactivación Metabólica/genética , Metabolismo de los Lípidos/efectos de los fármacos , Extractos Vegetales/química , ARN Interferente Pequeño/genética , ARN Interferente Pequeño/metabolismo , Receptores Citoplasmáticos y Nucleares/antagonistas & inhibidores , Receptores Citoplasmáticos y Nucleares/metabolismo , Rizoma/química , Transducción de Señal
17.
Gene ; 538(2): 251-7, 2014 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-24487090

RESUMEN

Nickel is an essential micronutrient due to its involvement in many enzymatic reactions as a cofactor. However, excess of this element is toxic to biological systems. Here, we constructed a cDNA library from Beta maritima and screened it in the yeast system to identify genes that confer resistance to toxic levels of nickel. A cDNA clone (NIC6), which encodes for a putative membrane protein with unknown function, was found to help yeast cells to tolerate toxic levels of nickel. A GFP fused form of Nic6 protein was localized to multivesicular structures in tobacco epidermal cells. Thus, our results suggest a possible role of Nic6 in nickel and intracellular ion homeostasis.


Asunto(s)
Beta vulgaris/genética , Beta vulgaris/metabolismo , ADN de Plantas/genética , Níquel/metabolismo , Secuencia de Aminoácidos , Secuencia de Bases , Beta vulgaris/efectos de los fármacos , Clonación Molecular , ADN Complementario/genética , Biblioteca de Genes , Genes de Plantas , Inactivación Metabólica/genética , Datos de Secuencia Molecular , Níquel/toxicidad , Proteínas de Plantas/genética , Proteínas de Plantas/metabolismo , Plantas Modificadas Genéticamente , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/metabolismo , Homología de Secuencia de Aminoácido , Nicotiana/genética , Nicotiana/metabolismo
18.
BMC Complement Altern Med ; 14: 72, 2014 Feb 23.
Artículo en Inglés | MEDLINE | ID: mdl-24559113

RESUMEN

BACKGROUND: Nuclear factor-erythroid 2 p45 related factor 2 (Nrf2) is a primary transcription factor, protecting cells from oxidative stress by regulating a number of antioxidants and phase II detoxifying enzymes. Dietary components such as sulforaphane in broccoli and quercetin in onions have been shown to be inducers of Nrf2. Piper betle (PB) grows well in tropical climate and the leaves are used in a number of traditional remedies for the treatment of stomach ailments and infections among Asians. The aim of this study was to elucidate the effect of Piper betle (PB) leaves extract in Nrf2 signaling pathway by using 2 types of cells; mouse embryonic fibroblasts (MEFs) derived from wild-type (WT) and Nrf2 knockout (N0) mice. METHODS: WT and N0 cells were treated with 5 and 10 µg/ml of PB for 10 and 12-h for the determination of nuclear translocation of Nrf2 protein. Luciferase reporter gene activity was performed to evaluate the antioxidant response element (ARE)-induction by PB. Real-time PCR and Western blot were conducted on both WT and N0 cells after PB treatment for the determination of antioxidant enzymes [superoxide dismutase (SOD1) and heme-oxygenase (HO-1)], phase I oxidoreductase enzymes [ NAD(P)H: quinone oxidoreductase (NQO1)] and phase II detoxifying enzyme [glutathione S-transferase (GST)]. RESULTS: Nuclear translocation of Nrf2 by PB in WT cells was better after 10 h incubation compared to 12 h. Real time PCR and Western blot analysis showed increased expressions of Nrf2, NQO1 and GSTA1 genes with corresponding increases in glutathione, NQO1 and HO-1 proteins in WT cells. Reporter gene ARE was stimulated by PB as shown by ARE/luciferase assay. Interestingly, PB induced SOD1 gene and protein expressions in N0 cells but not in WT cells. CONCLUSION: The results of this study confirmed that PB activated Nrf2-ARE signaling pathway which subsequently induced some phase I oxidoreductase, phase II detoxifying and antioxidant genes expression via ARE reporter gene involved in the Nrf2 pathway with the exception of SOD1 which may not be dependent on this pathway.


Asunto(s)
Elementos de Respuesta Antioxidante , Antioxidantes/metabolismo , Inactivación Metabólica/genética , Factor 2 Relacionado con NF-E2/metabolismo , Estrés Oxidativo/efectos de los fármacos , Piper betle , Extractos Vegetales/farmacología , Animales , Fibroblastos/efectos de los fármacos , Fibroblastos/metabolismo , Expresión Génica/efectos de los fármacos , Glutatión/metabolismo , Glutatión Transferasa/metabolismo , Fase I de la Desintoxicación Metabólica/genética , Fase II de la Desintoxicación Metabólica/genética , Ratones , NAD(P)H Deshidrogenasa (Quinona)/metabolismo , Transducción de Señal
19.
Mol Med Rep ; 9(2): 669-76, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24276478

RESUMEN

Cinnamaldehyde is an active monomer isolated from the stem bark of Cinnamomum cassia, a traditional oriental medicinal herb, which is known to possess marked antitumor effects in vitro and in vivo. The aim of the present study was to examine the potential advantages of using cinnamaldehyde in combination with chemotherapeutic agents commonly used in colorectal carcinoma (CRC) therapy, as well as to investigate the effect of cinnamaldehyde on chemotherapeutic-associated gene expression. The synergistic interaction of cinnamaldehyde and chemotherapeutic agents on human CRC HT-29 and LoVo cells was evaluated using the combination index (CI) method. The double staining with Annexin V conjugated to fluorescein-isothiocyanate and phosphatidylserine was employed for apoptosis detection. The expression of drug-metabolizing genes, including excision repair cross­complementing 1 (ERCC1), orotate phosphoribosyltransferase (OPRT), thymidylate synthase (TS), breast cancer susceptibility gene 1 (BRCA1) and topoisomerase 1 (TOPO1), all in HT-29 and LoVo cells, with or without the addition of cinnamaldehyde, was examined by quantitative polymerase chain reaction (PCR). Cinnamaldehyde had a synergistic effect on the chemotherapeutic agents cytotoxicity in HT-29 and LoVo cells. In addition, cinnamaldehyde suppressed BRCA1, TOPO1, ERCC1 and TS mRNA expression, except for OPRT expression, which was markedly upregulated. Our findings indicate that cinnamaldehyde appears to be a promising candidate as an adjuvant in combination therapy with 5-fluorouracil (5-FU) and oxaliplatin (OXA), two chemotherapeutic agents used in CRC treatment. The possible mechanisms of its action may involve the regulation of drug­metabolizing genes.


Asunto(s)
Acroleína/análogos & derivados , Neoplasias Colorrectales/tratamiento farmacológico , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Inactivación Metabólica/genética , Acroleína/administración & dosificación , Acroleína/química , Acroleína/farmacocinética , Protocolos de Quimioterapia Combinada Antineoplásica , Proteína BRCA1/biosíntesis , Cinnamomum aromaticum/química , Neoplasias Colorrectales/metabolismo , ADN-Topoisomerasas de Tipo I/biosíntesis , Proteínas de Unión al ADN/biosíntesis , Sinergismo Farmacológico , Endonucleasas/biosíntesis , Fluorouracilo/administración & dosificación , Células HT29 , Humanos , Compuestos Organoplatinos/administración & dosificación , Orotato Fosforribosiltransferasa/biosíntesis , Oxaliplatino , Timidilato Sintasa/biosíntesis
20.
Proc Natl Acad Sci U S A ; 110(22): 8842-6, 2013 May 28.
Artículo en Inglés | MEDLINE | ID: mdl-23630255

RESUMEN

As a managed pollinator, the honey bee Apis mellifera is critical to the American agricultural enterprise. Recent colony losses have thus raised concerns; possible explanations for bee decline include nutritional deficiencies and exposures to pesticides and pathogens. We determined that constituents found in honey, including p-coumaric acid, pinocembrin, and pinobanksin 5-methyl ether, specifically induce detoxification genes. These inducers are primarily found not in nectar but in pollen in the case of p-coumaric acid (a monomer of sporopollenin, the principal constituent of pollen cell walls) and propolis, a resinous material gathered and processed by bees to line wax cells. RNA-seq analysis (massively parallel RNA sequencing) revealed that p-coumaric acid specifically up-regulates all classes of detoxification genes as well as select antimicrobial peptide genes. This up-regulation has functional significance in that that adding p-coumaric acid to a diet of sucrose increases midgut metabolism of coumaphos, a widely used in-hive acaricide, by ∼60%. As a major component of pollen grains, p-coumaric acid is ubiquitous in the natural diet of honey bees and may function as a nutraceutical regulating immune and detoxification processes. The widespread apicultural use of honey substitutes, including high-fructose corn syrup, may thus compromise the ability of honey bees to cope with pesticides and pathogens and contribute to colony losses.


Asunto(s)
Abejas/inmunología , Colapso de Colonias/inducido químicamente , Ácidos Cumáricos/farmacología , Regulación de la Expresión Génica/inmunología , Miel/análisis , Inactivación Metabólica/inmunología , Intoxicación por Organofosfatos/inmunología , Animales , Péptidos Catiónicos Antimicrobianos/metabolismo , Abejas/genética , Cromatografía Líquida de Alta Presión , Cumafos/toxicidad , Ácidos Cumáricos/química , Sistema Enzimático del Citocromo P-450/genética , Sistema Enzimático del Citocromo P-450/metabolismo , Flavanonas/química , Flavanonas/farmacología , Regulación de la Expresión Génica/efectos de los fármacos , Secuenciación de Nucleótidos de Alto Rendimiento , Inactivación Metabólica/genética , Polen/química , Propionatos , Própolis/química , Reacción en Cadena en Tiempo Real de la Polimerasa , Espectrometría de Masas en Tándem
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA